Crossmark

Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy

Crossref DOI link: https://doi.org/10.1038/s41408-022-00711-8

Published Online: 2022-08-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Frechette, Kelsey M.

Lester, Scott C.

Taparra, Kekoa https://orcid.org/0000-0001-8493-3868
Breen, William G.

Martenson, James A.

Hoppe, Bradford S.

Peterson, Jennifer L.

Rule, William G.

Stafford, Scott L.

Stish, Bradley J.

Habermann, Thomas M.

Young, Jason R. https://orcid.org/0000-0001-5351-8266
Harmsen, William S.

Laack, Nadia N. https://orcid.org/0000-0002-4385-6349
License Information

Text and Data Mining valid from 2022-08-22

Version of Record valid from 2022-08-22
More Information

Article History

Received: 21 December 2021

Revised: 8 July 2022

Accepted: 22 July 2022

First Online: 22 August 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below